We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UCB:EURONEXT BRUSSELSUCB S.A. Analysis

Data as of 2026-03-10 - not real-time

$30.59

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

United Community Banks is trading at $30.59, well below its DCF-derived fair value of roughly $49.6, suggesting a material price discount. The stock’s trailing PE of 11.7 is considerably lower than the industry average of 17.4, reinforcing the undervaluation case. A dividend yield of 3.27% combined with a modest payout ratio of 37% points to a sustainable income stream. Technicals show the RSI at about 30, indicating oversold conditions, while the MACD remains bearish. The 30‑day volatility exceeds 30% and beta hovers around 1.0, implying market‑line risk but heightened price swings. Support sits near $29.38 and the current price remains comfortably above it, offering a limited downside cushion.
Recent corporate actions include a $100 million share repurchase program and the redemption of all outstanding 6.875% Series I preferred shares, returning capital to shareholders. Revenue grew at a healthy 10.5% year‑over‑year, and operating margins are strong at roughly 46%. The balance sheet shows ample cash of $431 million against modest debt, resulting in a near‑zero debt‑to‑equity ratio. The combination of attractive valuation, solid earnings growth, and a reliable dividend makes the stock a compelling value play. However, the neutral trend direction and bearish MACD suggest that upside may be incremental in the near term. Investors should monitor volume trends, which are currently increasing, as a potential catalyst for price appreciation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI near oversold levels
  • Price positioned above near‑term support
  • Increasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates ~22% upside
  • Revenue growth of 10.5% YoY
  • Attractive dividend yield of 3.27%

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend payout ratio
  • Strong operating margin and cash generation
  • Low leverage with near‑zero debt‑to‑equity

Key Metrics & Analysis

Financial Health

Revenue Growth10.50%
Profit Margin32.34%
P/E Ratio11.7
ROE9.28%
ROA1.18%
P/B Ratio1.0
Op. Cash Flow$384.0M
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI30.4
Support$29.38
Resistance$36.50
MA 20$33.58
MA 50$33.59
MA 200$31.49
MACDBearish
VolumeIncreasing
Fear & Greed Index75

Valuation

Fair Value$49.62
Target Price$37.33
Upside/Downside22.04%
GradeUndervalued
TypeValue
Dividend Yield3.27%

Risk Assessment

Beta1.04
Volatility30.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.